openPR Logo
Press release

Global Pharmacovigilance Market Growth Rate A CAGR of 13% During The Forecast 2014 - 2020

10-16-2017 10:47 AM CET | Health & Medicine

Press release from: (MRE) Report

Pharmacovigilance Market

Pharmacovigilance Market

In this report, the global pharmacovigilance market is segmented by clinical trial phase, service provider, and region. On the basis of clinical trial phase, the market is segmented into preclinical, phase I, phase II, phase III, and phase IV. The market on the basis of service provider is segmented into in-house and contract outsourcing. Contract outsourcing dominated the market in 2015 and is expected to continue its dominance during the forecast period. This growth is attributed to the increasing focus of pharmaceutical companies on core business activities by outsourcing pharmacovigilance-related services to specialized firms.

The global pharmacovigilance market size was US$ 2.5 billion in 2014 and is projected to register a compound annual growth rate (CAGR) of 13% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market

Quintiles Transnational Corporation, Accenture Plc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, PAREXEL International Corporation, Janssen Research & Development LLC, Pharmaceutical Product Development Inc., United BioSource Corporation, Synowlwedge LLC, Cognizant Technology Solutions Corporation, Covance Inc., and ICON, Plc. are the most active players in the pharmacovigilance market.

The increasing need of pharmacovigilance owing to rising prevalence of adverse drug reaction is a major factor driving the market. In addition, the rise in the intricacy of drug safety regulation by government and the growing demand from the paints & coatings industry are expected to fuel the growth of the market.

The Pharmacovigilance Market has been segmented as below:

by Clinical Trial Phase
• Pre clinical
• Phase I
• Phase II
• Phase III
• Phase IV

by Type of Service Provider
• In- House
• Contract outsourcing

by Region
• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

This report covers the pharmacovigilance market, in terms of value, and forecasts the market size till 2020. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global pharmacovigilance market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Sample Report: https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market

The deep-dive study on the pharmacovigilance market will help customers with the identification of new market opportunities and targeted promotional plans.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Pharmacovigilance and Drug Safety Software Market, By Functionality
8 Pharmacovigilance and Drug Safety Software Market, By Delivery Mode
9 Pharmacovigilance and Drug Safety Software Market, By End-Users
10 Geographic Analysis
11 Competitive Landscape
12 Company Profile
12.1 AB-Cube
12.2 Arisglobal
12.3 Extedo GMBH.
12.4 Ennov.
12.5 Online Business Applications, Inc
12.6 Oracle Corporation.
12.7 Sarjen Systems Pvt. Ltd
12.8 Sparta Systems, Inc
12.9 United Biosource Corporation
12.1 Umbra Global

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmacovigilance Market Growth Rate A CAGR of 13% During The Forecast 2014 - 2020 here

News-ID: 774356 • Views:

More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018: Weight Management Market 2018 The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018: Home Healthcare Market 2018 The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018: Healthcare 3D Printing Market 2018 The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018: Tumor Ablation Market 2018 The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed

All 5 Releases


More Releases for Pharmacovigilance

Pharmacovigilance Outsourcing Market 2021 | Detailed Report
Pharmacovigilance Outsourcing Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Pharmacovigilance Outsourcing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4964765 The report provides a comprehensive analysis of company profiles listed below: - Clinquest Group B.V - Cognizant - LabCorp - IBM -
Global Pharmacovigilance Market & Forecasts
According to a new market research report published by Global Market Estimates, the Global Pharmacovigilance Market is expected to grow at a CAGR of 13.55% during the forecast period. The demand for pharmacovigilance is projected to be high due to the increasing demand for pharmacovigilance services and rising cost-effective initiatives for SMEs companies. Browse 145 Market Data Tables and 118 Figures spread through 168 Pages and in-depth TOC on "Pharmacovigilance Market
Pharmacovigilance and Drug Safety Software Market: Pharmacovigilance and Drug Sa …
The global pharmacovigilance and drug safety software market is projected to create new opportunities in the coming years on account of the escalating complexity of drug safety regulations. Among the key contributing factors of the market could be tighter regulatory inspections implemented to control the rise of the incidences of drug-associated adverse events and spiraling concerns pertaining to patient safety. Pharmaceutical and biotechnology companies are predicted to largely adopt pharmacovigilance software
Rising Number of Government Pharmacovigilance Centers to Boost Pharmacovigilance …
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of
Pharmacovigilance Market | Forecast up to 2020
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of
Pharmacovigilance Market Research Report Forecast to 2020
Pharmacovigilance is a crucial component of an effective drug regulation system and is used for evaluating and monitoring adverse drug reactions. Pharmacovigilance activities are essential for conducting clinical research. Currently, the global network of pharmacovigilance centers is operating effectively to assure appropriate functioning of drug safety procedures. The large volume of international adverse drug reaction reports collected and stored in a central database assists the national drug regulatory authorities to